
Annual report 2022
added 10-07-2022
Allied Healthcare Products EPS Ratio 2011-2026 | AHPI
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.48 | -0.29 | 0.17 | -0.53 | -0.55 | -0.52 | -0.57 | -0.44 | -0.35 | -0.16 | -0.05 | 0.03 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.17 | -0.57 | -0.312 |
Quarterly EPS Ratio Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -0.32 | -0.29 | -0.25 | 0.39 | -0.1 | 0.17 | -0.04 | 0.17 | -0.08 | -0.38 | -0.15 | -0.38 | 0.09 | -0.19 | -0.31 | -0.19 | -0.22 | -0.09 | -0.19 | -0.09 | -0.1 | -0.09 | -0.2 | -0.09 | -0.2 | -0.18 | -0.14 | -0.09 | -0.06 | -0.01 | -0.09 | -0.01 | -0.12 | -0.11 | -0.07 | -0.01 | -0.03 | -0.06 | -0.05 | -0.06 | -0.05 | - | -0.02 | - | 0.01 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.39 | -0.38 | -0.0995 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | ||
|
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-0.59 | $ 1.35 | - | $ 21.8 M | ||
|
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
-2.33 | $ 11.72 | -1.26 % | $ 464 M | ||
|
LENSAR
LNSR
|
-2.73 | $ 5.56 | -8.4 % | $ 64 M | ||
|
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
-0.34 | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
1.52 | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Penumbra
PEN
|
4.57 | $ 334.17 | -0.41 % | $ 13 B | ||
|
Electromed
ELMD
|
0.89 | $ 24.7 | 0.86 % | $ 209 M | ||
|
Insulet Corporation
PODD
|
3.51 | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Cytosorbents Corporation
CTSO
|
-0.38 | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
-8.58 | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
1.5 | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | ||
|
Quanterix Corporation
QTRX
|
-2.51 | $ 3.82 | -3.05 % | $ 163 M | ||
|
AdaptHealth Corp.
AHCO
|
-0.52 | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
-0.37 | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-0.91 | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
-0.54 | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.91 | 4.83 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
-5.37 | $ 3.53 | -2.35 % | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
4.95 | $ 52.07 | -0.17 % | $ 1.53 B | ||
|
Sintx Technologies
SINT
|
-6.16 | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
Pulmonx Corporation
LUNG
|
-1.33 | $ 1.31 | -5.76 % | $ 53.3 M | ||
|
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | ||
|
Sensus Healthcare
SRTS
|
-0.47 | $ 3.96 | -3.65 % | $ 64.7 M | ||
|
InspireMD
NSPR
|
-0.76 | $ 1.79 | 3.47 % | $ 115 M | ||
|
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
0.78 | - | - | $ 2.07 B | ||
|
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M |